23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.40%
Negative revenue growth while Insurance - Life median is 0.17%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-15.40%
Negative gross profit growth while Insurance - Life median is 0.17%. Seth Klarman would suspect poor product pricing or inefficient production.
-1.02%
Negative EBIT growth while Insurance - Life median is 2.29%. Seth Klarman would check if external or internal factors caused the decline.
-1.02%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
11.38%
Net income growth exceeding 1.5x Insurance - Life median of 7.39%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
11.37%
EPS growth exceeding 1.5x Insurance - Life median of 7.18%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
11.39%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 7.35%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
285.99%
OCF growth exceeding 1.5x Insurance - Life median of 36.54%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
285.99%
FCF growth exceeding 1.5x Insurance - Life median of 39.24%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
110.55%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 98.30%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
83.43%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 51.26%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
4.20%
3Y revenue/share growth near Insurance - Life median of 4.20%. Charlie Munger would note typical industry expansions over the short term.
No Data
No Data available this quarter, please select a different quarter.
436.41%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 54.00%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
76.46%
3Y OCF/share growth > 1.5x Insurance - Life median of 3.07%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
446.44%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 248.71% over a decade. Joel Greenblatt might see a standout compounder of earnings.
220.00%
5Y net income/share CAGR > 1.5x Insurance - Life median of 143.52%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
66.40%
3Y net income/share CAGR > 1.5x Insurance - Life median of 34.52%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
No Data
No Data available this quarter, please select a different quarter.
167.37%
5Y equity/share CAGR > 1.5x Insurance - Life median of 33.20%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
4.37%
3Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier suspects suboptimal short-term capital usage vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.89%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-6.47%
Negative BV/share change while Insurance - Life median is -0.73%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-7.31%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.